Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-03-017556
Filing Date
2003-05-08
Accepted
2003-05-08 16:33:09
Documents
6
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a2110555z10-ka.htm 10-K/A 610367
3 EX-10.28 a2110555zex-10_28.htm EX-10.28 29400
4 EX-10.29 a2110555zex-10_29.htm EX-10.29 10254
5 EX-23.1 a2110555zex-23_1.htm EX-23.1 2244
6 EX-99.1 a2110555zex-99_1.htm EX-99.1 8883
7 G749589.JPG g749589.jpg GRAPHIC 49139
  Complete submission text file 0001047469-03-017556.txt   712329
Mailing Address 240 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 240 E GRAND AVE SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-29889 | Film No.: 03688380
SIC: 2834 Pharmaceutical Preparations